Standex International Reports Q2 FY25 Results

Ticker: SXI · Form: 10-Q · Filed: Jan 31, 2025 · CIK: 310354

Sentiment: neutral

Topics: earnings, financials, quarterly-report

TL;DR

**Standex Intl (SXI) Q2 FY25: Revenue $3.17B, EPS $1.50. Cash from Ops $60M.**

AI Summary

Standex International Corp reported its second quarter fiscal year 2025 results for the period ending December 31, 2024. The company generated $3,170 million in revenue and $1.50 in diluted earnings per share. Key financial figures include $60,000,000 in net cash provided by operating activities and $11,986,117 in total assets.

Why It Matters

This filing provides investors with the latest financial performance of Standex International, impacting its stock valuation and future investment decisions.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report with standard financial disclosures.

Key Numbers

Key Players & Entities

FAQ

What was Standex International's revenue for the second quarter of fiscal year 2025?

Standex International reported revenue of $3,170 million for the second quarter of fiscal year 2025.

What was the diluted earnings per share for the period ending December 31, 2024?

The diluted earnings per share for the period ending December 31, 2024, was $1.50.

How much net cash did Standex International provide from operating activities in Q2 FY25?

In Q2 FY25, Standex International provided $60,000,000 in net cash from operating activities.

Who is the Chairman, President & CEO of Standex International?

David A. Dunbar is the Chairman, President & CEO of Standex International.

What is the company's fiscal year end?

Standex International's fiscal year ends on June 30.

Filing Stats: 4,572 words · 18 min read · ~15 pages · Grade level 17.8 · Accepted 2025-01-31 16:14:15

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION: Item 1. Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, 2024 (unaudited) 3 Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2024 and 2023 (unaudited) 4 Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended December 31, 2024 and 2023 (unaudited) 5 Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended December 31, 2024 and 2023 (unaudited) 6 Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2024 and 2023 (unaudited) 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 29 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 40 Item 4.

Controls and Procedures

Controls and Procedures 41

OTHER INFORMATION

PART II. OTHER INFORMATION: Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42 Item 5. Other Information 42 Item 6. Exhibits 43 2

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION ITEM 1 STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES Unaudited Condensed Consolidated Balance Sheets December 31, June 30, (In thousands, except share and per share data) 2024 2024 ASSETS Current assets: Cash and cash equivalents $ 121,147 $ 154,203 Accounts receivable, less allowance for credit losses of $ 3,170 and $ 1,882 at December 31, 2024 and June 30, 2024, respectively 153,172 121,365 Inventories 103,984 87,106 Contract assets 55,599 45,393 Prepaid expenses and other current assets 31,020 22,028 Total current assets 464,922 430,095 Property, plant, and equipment, net 137,613 134,963 Intangible assets, net 207,504 78,673 Goodwill 586,712 281,283 Deferred tax asset 21,981 17,450 Operating lease right-of-use asset 39,987 37,078 Other non-current assets 24,219 25,515 Total non-current assets 1,018,016 574,962 Total assets $ 1,482,938 $ 1,005,057 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 73,390 $ 63,364 Accrued liabilities 59,584 56,698 Income taxes payable 5,179 7,503 Total current liabilities 138,153 127,565 Long-term debt 534,297 148,876 Operating lease long-term liabilities 33,914 30,725 Accrued pension and other non-current liabilities 93,905 76,388 Total non-current liabilities 662,116 255,989 Contingencies (Note 15) Redeemable noncontrolling interest 26,635 - Stockholders' equity: Common stock, par value $ 1.50 per share, 60,000,000 shares authorized, 27,984,278 shares issued, 11,986,117 and 11,761,700 shares outstanding at December 31, 2024 and June 30, 2024 41,976 41,976 Additional paid-in capital 132,327 106,193 Retained earnings 1,097,857 1,086,277 Accumulated other comprehensive loss ( 187,769 ) ( 182,956 ) Treasury shares: 15,998,161 and 16,222,578 shares at December 31, 2024 and June 30, 2024 ( 428,357 ) ( 429,987 ) Total stockholders' equity 656,034 621,503 Total liabilit

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing